Résultats: 681

    Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis

    Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations that wo...

    Guideline: daily iron supplementation in infants and children

    This guideline provides global, evidence-informed recommendations on daily iron supplementation in infants and children, as a public-health intervention for the prevention of anaemia and iron deficiency. It includes recommendations for iron supplementation in countries where malaria is prevalent. The gui...

    Guideline: daily iron supplementation in adult women and adolescent girls

    This guideline provides a global, evidence-informed recommendation on daily iron supplementation in menstruating adult women and adolescents, as a public-health intervention for the prevention of anaemia and iron deficiency. The guideline aims to help Member States and their partners in their efforts to ...

    WHO guidelines for the treatment of Chlamydia trachomatis

    Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...

    WHO guidelines for the treatment of genital herpes simplex virus

    Rationale for the guidelines: Since the publication of the World Health Organization (WHO) Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These gui...

    WHO guidelines for the treatment of Treponema pallidum (syphilis)

    Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...

    WHO guidelines for the treatment of neisseria gonorrhoeae

    Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...

    Updates on HIV and infant feeding: the duration of breastfeeding and support from health services to improve feeding practices among mothers living with HIV

    WHO guidelines on HIV and Infant Feeding in 2010 for the first time recommended the use of antiretroviral drugs to prevent postnatal transmission of HIV through breastfeeding. This resulted in a major change from an individualised counselling approach toward a public health approach regarding how materna...

    Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

    The field of HCV therapeutics continues to evolve rapidly and, since the World Health Organization (WHO) issued its first Guidelines for the screening, care and treatment of persons with hepatitis C infection in 2014, several new medicines have been approved by at least one stringent regulatory authority...

    Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach

    These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and car...